BIOLIT ApS: Financial statements 2024
CVR: 10068460
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 60,205 and a net result of DKK 13,041,006 compared with DKK 4,787,957 the year before. That is a decrease of 93.8% compared with the year before. Equity amounted to DKK 31,379,243. The solvency ratio was 68.2%.
- Gross Profit
- 60,205 kr.
- Profit/Loss
- 13,041,006 kr.
- Equity
- 31,379,243 kr.
- Total Assets
- 46,027,486 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 60 t. | 13 mio. | 31.4 mio. | 0 |
| 2023 | - | 974 t. | 4.8 mio. | 18.3 mio. | 0 |
| 2022 | - | 2.4 mio. | 3.2 mio. | 13.6 mio. | 0 |
| 2021 | - | 1.8 mio. | 1.6 mio. | 10.4 mio. | 0 |
| 2020 | - | 1.5 mio. | 1.7 mio. | 8.8 mio. | - |
How creditworthy is BIOLIT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of September 27, 2024, Thomas Velin has joined the board of directors of BIOLIT ApS.
As of September 27, 2024, Niels Ebbe Valdal has left the board of directors of BIOLIT ApS.
As of September 26, 2024, Thomas Velin has left the board of directors of BIOLIT ApS.
About BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.
